Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus

Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus

SGLT-2 inhibitor, traditionally used for glycemic control, has several beneficial effects that can help manage heart failure (HF). SGLT-2 inhibitors reduce the risk of cardiovascular mortality in patients with HF. As atrial fibrillation (AF) is closely associated with HF and diabetes mellitus (DM) i...

Full description

Bibliographic Details
Main Authors: Kyuhyun Lee, Soo Kyoung Lee, Juyeon Lee, Bo Kyung Jeon, Tae-Hoon Kim, Hee Tae Yu, Jung Myung Lee, Jin-Kyu Park, Yong-Soo Baek, Dong Hyeok Kim, Jaemin Shim, Boyoung Joung, Moon-Hyoung Lee, Hui-Nam Pak, Junbeom Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847966/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847966/?tool=EBI

Similar Items